Maximal Androgen Blockade Versus Castration Alone In Patients With Metastatic Prostate Cancer
Abeer Abdalla Mahmoud;
Abstract
Maximum androgen blockade, consisting of an anti-androgen plus either a luteinizing hormone-releasing hormone agonist (LHRHA) or orchiectomy, is standard care for patients with prostate cancer (Klotz, 2004). To further elucidate the effect of adding a
Other data
| Title | Maximal Androgen Blockade Versus Castration Alone In Patients With Metastatic Prostate Cancer | Other Titles | التثبيط الأقصى للأندروجين مقابل الإخصاء وحده في المرضى المصابين بسرطان البروستاتا المنتشر | Authors | Abeer Abdalla Mahmoud | Keywords | Maximal Androgen Blockade Versus Castration Alone In Patients With Metastatic Prostate Cancer | Issue Date | 2013 | Description | Maximum androgen blockade, consisting of an anti-androgen plus either a luteinizing hormone-releasing hormone agonist (LHRHA) or orchiectomy, is standard care for patients with prostate cancer (Klotz, 2004). To further elucidate the effect of adding a |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 115081A5263.pdf | 333.06 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.